hotspot -WSS

hotspot

author：leisure time 2025-10-02 22:25:02 - browse：9

Three boxes of Wegovy stands in a line — coverage from STAT — Steffen Trumpf/picture alliance/Getty Images

WASHINGTON — Novo Nordisk’s newly won permission to market the heart benefits of its obesity drug Wegovy could provide a backdoor way to expand access to the drug for people on Medicare, experts told STAT.

Currently, Medicare is prohibited by law from covering medications for obesity treatment alone. While companies that manufacture wildly popular anti-obesity medications and their allies haven’t been successful in lobbying Congress to change the law, the Food and Drug Administration’s move could give doctors an avenue to prescribe the medications to some Medicare patients.

Wegovy’s new label indicates that the drug can be used to reduce the risk of major heart complications for people who are overweight or obese and have existing heart disease, Novo said in a statement Friday.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： How to save PrEP access — and even expand it
Next article： NIH trials fail to test meaningful long Covid therapies, experts say

focus

leisure time

WSS

Biden, Billy Joel, Elton John lead tributes for Tony Bennett after singer's death at 96

Dispute over threat of extinction posed by artificial intelligence looms over surging industry

What is the Turing Test that determines if computers can think?

Anavex keeps shifting the goalposts in its clinical trials

Grand jury probing Trump's efforts to overturn 2020 election did not meet Friday: Sources

Naloxone nonprofit donates 200,000 doses after FDA approval

hotspot

hotspot

Wikipedia

Malaria cases in Florida and Texas: Here’s what you need to know

Jack Smith previously got search warrant for Trump's Twitter, new court docs show

New air purifier tech could be key to improving indoor air quality

Wegovy trial has doctors encouraged over new possibilities

Heart attack and stroke risk calculators need revising

Why Marc Tessier

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Naloxone nonprofit donates 200,000 doses after FDA approval

New air purifier tech could be key to improving indoor air quality

Biden White House, tech companies launch new safeguards around emerging AI technology

focus

Hawaii wildfires fueled by Hurricane Dora's winds prompt evacuations

Listen: Merck v. USA, the best of ASCO, and Leqembi at the FDA

A new deal aims to ramp up use of AI in rehab care decisions

What is the Turing Test that determines if computers can think?

'The View' co

Family of Gilgo Beach murder suspect releases statement: 'Devastating time'

entertainment

focus

leisure time

explore